---
title: "Mesco Pharmaceuticals Ltd (MESCOPHARM) — Share Price, Financials & Analysis"
symbol: "MESCOPHARM"
company: "Mesco Pharmaceuticals Ltd"
canonical: "https://tapetide.com/stocks/MESCOPHARM"
sector: "Healthcare"
industry: "Pharmaceuticals & Biotechnology"
generated_at: "2026-09-13T19:03:44.372Z"
---

# Mesco Pharmaceuticals Ltd (MESCOPHARM)

Canonical page: https://tapetide.com/stocks/MESCOPHARM

## Company

- **Sector:** Healthcare
- **Industry:** Pharmaceuticals & Biotechnology
- **Macro Sector:** Healthcare
- **Stock Type:** EQUITY
- **Face Value:** ₹10
- **F&O Eligible:** No
- **Website:** mescopharma.com

## About

Mesco Pharmaceuticals is engaged in the business of manufactures and distributes a wide range of pharmaceutical products. The Company manufactures bulk drugs and formulations which are sold domestically in India and abroad.(Source : Company Web-site)

## Latest Price

## Growth Rates

| Metric | 1Y |
| --- | --- |
| net income growth | 100% |

## Financial Statements

### Quarterly Results

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2019 | Jun 2019 | Sep 2019 | Dec 2019 | Mar 2020 | Jun 2020 | Sep 2020 | Dec 2020 | Mar 2021 | Jun 2021 | Sep 2021 | Dec 2021 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Expenses | 0.02 | 0.09 | 0.01 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating Profit | -0.02 | -0.09 | -0.01 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit before tax | -0.02 | -0.09 | -0.01 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Tax % | 0 | 0 | 0 | — | — | — | — | — | — | — | — | — |
| Net Profit | -0.02 | -0.09 | -0.01 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS in Rs | -0.01 | -0.04 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |

### Profit & Loss

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | TTM |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Expenses | 0 | 0 | 0.01 | 0.26 | 0.09 | 0.41 | 0.1 | 0 | 0 |
| Operating Profit | 0 | 0 | -0.01 | -0.26 | -0.09 | -0.41 | -0.1 | 0 | 0 |
| Other Income | 0.03 | 0 | 0.04 | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest | 0.03 | 0.21 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Depreciation | 0 | 46.56 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit before tax | 0 | -46.77 | 0.03 | -0.26 | -0.09 | -0.41 | -0.1 | 0 | 0 |
| Tax % | — | -1.35 | 33.33 | 0 | 0 | 0 | 0 | — | — |
| Net Profit | 0 | -46.14 | 0.02 | -0.26 | -0.09 | -0.41 | -0.1 | 0 | 0 |
| EPS in Rs | 0 | -22.71 | 0.01 | -0.13 | -0.04 | -0.2 | -0.05 | 0 | 0 |
| Dividend Payout % | — | 0 | 0 | 0 | 0 | 0 | 0 | — | — |

### Balance Sheet

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Sep 2021 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Equity Capital | 19.74 | 19.74 | 19.74 | 19.74 | 19.74 | 19.74 | 19.74 | 19.74 | 19.74 |
| Reserves | 16.22 | -29.92 | -29.9 | -30.16 | -30.24 | -30.65 | -30.75 | -30.76 | -30.76 |
| Borrowings | 10.98 | 11.18 | 10.39 | 10.66 | 10.75 | 11.14 | 11.22 | 11.18 | 11.18 |
| Other Liabilities | 1.39 | 0 | 0.02 | 0.01 | 0 | 0.02 | 0 | 0.03 | 0.02 |
| Total Liabilities | 48.33 | 1 | 0.25 | 0.25 | 0.25 | 0.25 | 0.21 | 0.19 | 0.18 |
| Fixed Assets | 19.12 | 0.16 | 0.18 | 0.18 | 0.18 | 0.18 | 0.18 | 0.18 | 0.18 |
| CWIP | 28.13 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | 0.08 | 0.03 | 0.03 | 0.03 | 0.03 | 0.03 | 0 | 0 | 0 |
| Other Assets | 1 | 0.81 | 0.04 | 0.04 | 0.04 | 0.04 | 0.03 | 0.01 | 0 |
| Total Assets | 48.33 | 1 | 0.25 | 0.25 | 0.25 | 0.25 | 0.21 | 0.19 | 0.18 |

### Cash Flow

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash from Operating Activity | — | -0.22 | 0.03 | -0.26 | -0.09 | -0.39 | -0.08 | 0 |
| Cash from Investing Activity | — | 0 | -0.02 | 0 | 0 | 0 | 0 | 0 |
| Cash from Financing Activity | — | 0.21 | 0.02 | 0.26 | 0.09 | 0.39 | 0.08 | -0.03 |
| Net Cash Flow | — | -0.01 | 0.04 | 0 | 0 | 0 | 0 | -0.04 |
| Free Cash Flow | — | -0.22 | 0.01 | -0.26 | -0.09 | -0.39 | -0.08 | 0 |
| CFO/OP | — | — | -400 | 100 | 100 | 95 | 80 | — |

### Ratios

| Item | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| ROCE % | — | -194.24 | 4.88 | -110.64 | -36.73 | -170.83 | -45.45 | 0 |

## Shareholding Pattern

### annual

| Category | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Dec 2020 |
| --- | --- | --- | --- | --- | --- | --- |
| Promoters | 39.3% | 39.3% | 39.3% | 39.3% | 39.3% | 39.3% |
| Public | 60.7% | 60.7% | 60.7% | 60.7% | 60.7% | 60.7% |
| No. of Shareholders | 40830 | 40820 | 40789 | 40722 | 40739 | 40733 |

### Quarterly

| Category | Mar 2018 | Jun 2018 | Sep 2018 | Dec 2018 | Mar 2019 | Jun 2019 | Sep 2019 | Dec 2019 | Mar 2020 | Jun 2020 | Sep 2020 | Dec 2020 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Promoters | 39.3% | 39.3% | 39.3% | 39.3% | 39.3% | 39.3% | 39.3% | 39.3% | 39.3% | 39.3% | 39.3% | 39.3% |
| Public | 60.7% | 60.7% | 60.7% | 60.7% | 60.7% | 60.7% | 60.7% | 60.7% | 60.7% | 60.7% | 60.7% | 60.7% |
| No. of Shareholders | 40789 | 40784 | 40782 | 40773 | 40722 | 40733 | 40735 | 40735 | 40739 | 40740 | 40740 | 40733 |

## Technical Indicators

Derived from daily closing prices and recomputed each trading session; values move with the market.

- **Overall Signal:** Sell
- **Buy / Neutral / Sell:** 4 / 7 / 8

### Moving Averages — summary: **Strong Sell**

| Indicator | Value | Signal |
| --- | --- | --- |
| SMA (10) | 8.98 | Buy |
| EMA (10) | 9.29 | Buy |
| SMA (20) | 10.51 | Sell |
| EMA (20) | 10.24 | Sell |
| SMA (50) | 13.92 | Sell |
| EMA (50) | 13.2 | Sell |
| SMA (100) | 19.78 | Sell |
| EMA (100) | 14.16 | Sell |
| SMA (200) | — | Neutral |
| EMA (200) | — | Neutral |

### Oscillators — summary: **Neutral**

| Indicator | Value | Signal |
| --- | --- | --- |
| RSI (14) | 39.73 | Neutral |
| MACD (12,26,9) | -1.43 | Buy |
| Stochastic (14,3,3) | 32.62 | Neutral |
| ADX (14) | 36.33 | Buy |
| Williams %R (14) | -50.44 | Neutral |
| ATR (14) | 0.55 | High Volatility |
| ROC (12) | -10.71 | Sell |
| Stoch RSI (14) | 100 | Sell |
| UO (7,14,28) | 47.01 | Neutral |

## Filings & Documents

### Annual Reports

| Date | Document |
| --- | --- |
| from bse | [Annual Report 2021 from bse](https://www.bseindia.com/bseplus/AnnualReport//72521500274.pdf) |
| from bse | [Annual Report 2020 from bse](https://www.bseindia.com/bseplus/AnnualReport//66589500274.pdf) |
| from bse | [Annual Report 2019 from bse](https://www.bseindia.com/bseplus/AnnualReport//5002740319.pdf) |
| from bse | [Annual Report 2018 from bse](https://www.bseindia.com/bseplus/AnnualReport//5002740318.pdf) |
| from bse | [Annual Report 2017 from bse](https://www.bseindia.com/bseplus/AnnualReport//5002740317.pdf) |
| from bse | [Annual Report 2016 from bse](https://www.bseindia.com/bseplus/AnnualReport//5002740316.pdf) |
| from bse | [Annual Report 2015 from bse](https://www.bseindia.com/bseplus/AnnualReport//5002740315.pdf) |

---

Provenance differs by section. Financial statements, shareholding and filings are as reported in company disclosures to NSE/BSE/SEBI. Price, volume and 52-week levels are exchange market data. Technical indicators are computed by Tapetide from daily closing prices. The Tapetide Score is Tapetide's own analysis. Analyst ratings are third-party estimates, not company statements. All figures are for research and information only and are not investment advice. Generated 2026-09-13T19:03:44.372Z.